Potential Applications of Polymeric Microsphere Suspension as Subcutaneous Depot for Insulin

References

• Kawamori R. Practical concept for insulin therapy. Intern. Med. 1994; 73: 236–243
   Google Scholar
• Lassmann-Vague V., Guereci B., Hanaire-Broutin H., Leblanc H., Renard E., Thervet F. Ph. vague, pompes a insuline. Diabetes Metab. 1995; 21: 371–377
   Google Scholar
• Trehan A., Ali A. Recent approaches in insulin delivery. Drug Development and Industrial Pharmacy 1998; 24: 589–597
   PubMed Web of Science ®Google Scholar
• Haak T. New developments in the treatment of type-I diabetes mellitus. Exp. Clin. Endocrinol. Diabetes 1999; 107: S108–S113
   PubMed Web of Science ®Google Scholar
• Jeandidier N., Boivin S. Current status and future prospects of parenteral insulin regimens, strategies and delivery systems for diabetes treatment. Adv. Drug Deliv. Rev. 1999; 35: 179–198
   PubMed Web of Science ®Google Scholar
• Brange J., Volund A. Insulin analogs with improved pharmacokinetic profiles. Adv. Drug Deliv. Rev. 1999; 35: 307–335
   PubMed Web of Science ®Google Scholar
• Chetty D.J., Chien Y.W. Novel methods of insulin delivery: an update. Crit. Rev. Ther. Drug Carr. Syst. 1998; 15: 629–670
   PubMed Web of Science ®Google Scholar
• Ravi Kumar M.N.V., Neeraj Kumar. Polymeric controlled drug-delivery systems: Perspective issues and opportunities. Drug Development and Industrial Pharmacy 2000; 27: 1–30
   Web of Science ®Google Scholar
• Gander B., Meinel L., Walter E., Merkle H.P. Polymers as a platform for drug delivery: reviewing our current portfolio on poly(lactide-co-glycolide) (PLGA) microspheres. Chimia 2001; 55: 212–217
   Web of Science ®Google Scholar
• Vila A., Sanchez A., Tobio M., Calvo P., Alonso M.J. Design of biodegradable particles for protein delivery. J. Control. Rel. 2002; 78: 15–24
   PubMed Web of Science ®Google Scholar
• Edlund U., Albertsson A.C. Degradable polymer microspheres for controlled drug delivery. Degradable Aliphatic Polyesters, A.C. Albertsson. Springer, Germany 2002; 67–112
   Google Scholar
• Dash A.K., Cudworth G.C. Therapeutic applications of implantable drug delivery systems. J. Pharmacol. Toxicol. Methods 1998; 40: 1–12
   PubMed Web of Science ®Google Scholar
• Mank R., Rafler G., Nerlich B. Parenteral slow-release drugs on the basis of biodegradable polymers. Pharmazie 1991; 46: 9–18
   PubMed Web of Science ®Google Scholar
• Sung Y.K., Kim S.W. Advances in biodegradable polymers for drug delivery systems. Korea Polym. J. 2000; 8: 199–208
   Web of Science ®Google Scholar
• Amass W., Amass A., Tighe B. A review of biodegradable polymers: uses, current developments in the synthesis and characterization of biodegradable polyesters, blends of biodegradable polymers and recent advances in biodegradation studies. Polym. Int. 1998; 47: 89–144
   Web of Science ®Google Scholar
• Woo B.H., Na K.H., Dani B.A., Jiang G., Thanoo B.C., DeLuca P.P. In vitro characterization and in vivo testosterone suppression of 6-month release poly(d,l-lactide) leuprolide microspheres. Pharm. Res. 2002; 19: 546–550
   PubMed Web of Science ®Google Scholar
• Ambrosio M.R., Franceschetti P., Bondanelli M., Doga M., Maffei P., Baldelli R., Tamburrano G., Sicolo N., Giustina A., degli Uberti E.C. Efficacy and safety of the new 60-mg formulation of the long-acting somatostatin analog lanreotide in the treatment of acromegaly. Metab. Clin. Exp. 2002; 51: 387–393
   PubMed Web of Science ®Google Scholar
• Kostanski J.W., Thanoo B.C., DeLuca P.P. Preparation, characterization, and in vitro evaluation of 1- and 4-month controlled release orntide PLA and PLGA microspheres. Pharm. Dev. Technol. 2000; 5: 585–596
   PubMed Web of Science ®Google Scholar
• Johnson O.L., Cleland J.L., Lee H.J., Charnis M., Duenas E., Jaworowicz W., Shepard D., Shahzamani A., Jones A.J.S., Putney S.D. A month-long effect from a single injection of microencapsulated human growth hormone. Nat. Med. 1996; 2: 795–799
   PubMed Web of Science ®Google Scholar
• Desevaux C., Girard C., Lenaerts V., Dubreuil P. Characterization of subcutaneous contramid (R) implantation: host response and delivery of a potent analog of the growth hormone-releasing factor. Int. J. Pharm. 2002; 232: 119–129
   PubMed Web of Science ®Google Scholar
• Morishita M., Lowman A.M., Takayama K., Nagai T., Peppas N.A. Elucidation of the mechanism of incorporation of insulin in controlled release systems based on complexation polymers. J. Control. Rel. 2002; 81: 25–32
   PubMed Web of Science ®Google Scholar
• Singh M., Shirley B., Bajwa K., Samara E., Hora M., O'Hagan D. Controlled release of recombinant insulin-like growth factor from a novel formulation of polylactide-co-glycolide microparticles. J. Control. Rel. 2001; 70: 21–28
   PubMed Web of Science ®Google Scholar
• Yeh M.K. The stability of insulin in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol. J. Microencapsul. 2000; 17: 743–756
   PubMed Web of Science ®Google Scholar
• Shao P.G., Bailey L.C. Porcine insulin biodegradable polyester microspheres: stability and in vitro release characteristics. Pharm. Dev. Technol. 2000; 5: 1–9
   PubMed Web of Science ®Google Scholar
• Lam X.M., Duenas E.T., Daugherty A.L., Levin N., Cleland J.L. Sustained release of recombinant human insulin-like growth factor-I for treatment of diabetes. J. Control. Rel. 2000; 67: 281–292
   PubMed Web of Science ®Google Scholar
• Hu Y.Q., Guo J.X., Wang L.J., Tan R.X., Zhen L.Y. Preparation and evaluation of insulin-loaded polylactide microspheres using factorial design. Drug Development and Industrial Pharmacy 2000; 26: 1309–1313
   PubMed Web of Science ®Google Scholar
• Aboubakar M., Couvreur P., Pinto-Alphandary H., Gouritin B., Lacour B., Farinotti R., Puisieux F., Vauthier C. Insulin-loaded nanocapsules for oral administration: in vitro and in vivo investigation. Drug Dev. Res. 2000; 49: 109–117
   Web of Science ®Google Scholar
• Shao P.G., Bailey L.C. Stabilization of pH-induced degradation of porcine insulin in biodegradable polyester microspheres. Pharm. Dev. Technol. 1999; 4: 633–642
   PubMed Web of Science ®Google Scholar
• Bugamelli F., Raggi M.A., Orienti I., Zecchi V. Controlled insulin release from chitosan microparticles. Arch. Pharm. 1998; 331: 133–138
   PubMed Web of Science ®Google Scholar
• Uchida T., Yagi A., Oda Y., Nakada Y., Goto S. Instability of bovine insulin in poly(lactide-co-glycolide) (PLGA) microspheres. Chem. Pharm. Bull. 1996; 44: 235–236
   PubMed Web of Science ®Google Scholar
• Soriano I., Evora C., Llabres M. Preparation and evaluation of insulin-loaded poly(dl-lactide) microspheres using an experimental design. Int. J. Pharm. 1996; 142: 135–142
   Web of Science ®Google Scholar
• Moriyama K., Yui N. Regulated insulin release from biodegradable dextran hydrogels containing poly(ethylene glycol). J. Control. Rel. 1996; 42: 237–248
   Web of Science ®Google Scholar
• Cai Q., Bei J.Z., Wang S.G. Relationship among drug delivery behavior, degradation behavior and morphology of copolylactones derived from glycolide, l-lactide and epsilon-caprolactone. Polym. Adv. Technol. 2002; 13: 105–111
   Web of Science ®Google Scholar
• Sanchez E., Baro M., Soriano I., Perera A., Evora C. In vivo–in vitro study of biodegradable and osteointegrable gentamicin bone implants. Eur. J. Pharm. Biopharm. 2001; 52: 151–158
   PubMed Web of Science ®Google Scholar
• Negrin C.M., Delgado A., Llabres M., Evora C. In vivo-in vitro study of biodegradable methadone delivery systems. Biomaterials 2001; 22: 563–570
   PubMed Web of Science ®Google Scholar
• Brannon-Peppas L. Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug-delivery. Int. J. Pharm. 1995; 116: 1–9
   Web of Science ®Google Scholar
• Schwendeman S.P. Recent advances in the stabilization of proteins encapsulated in injectable PLGA delivery systems. Crit. Rev. Ther. Drug Carr. Syst. 2002; 19: 73–98
   PubMed Web of Science ®Google Scholar
• Kawashima Y., Yamamoto H., Takeuchi H., Fujioka S., Hino T. Pulmonary delivery of insulin with nebulized-lactide/glycolide copzolymer (PLGA) nanospheres to prolong hypoglycemic effect. J. Control. Rel. 1999; 62: 279–287
   PubMed Web of Science ®Google Scholar
• Perez M.H., Zinutti C., Lamprecht A., Ubrich N., Astier A., Hoffman M., Bodmeier R., Maincent P. The preparation and evaluation of poly(epsilon-caprolactone) microparticles containing both a lipophilic and a hydrophilic drug. J. Control. Rel. 2000; 65: 429–438
   PubMed Web of Science ®Google Scholar
• Ogawa Y., Yamamoto M., Okada H., Yashiki T., Shimamoto T. A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic/glycolic)acid. Chem. Pharm. Bull. 1988; 36: 1095–1103
   PubMed Web of Science ®Google Scholar
• Kim A., Yun M., Oh Y., Ahn W., Kim C. Pharmacodynamics of insulin in polyethylene glycol coated liposomes. Int. J. Pharm. 1999; 180: 75–81
   PubMed Web of Science ®Google Scholar
• Khaksa G., Nalini K., Bhat M., Udupa N. High performance liquid chromatographic determination of insulin in rat and human plasma. Anal. Biochem. 1998; 260: 92–95
   PubMed Web of Science ®Google Scholar
• Okada H. One- and three-month release injectable microspheres of the LH–RH superagonist leuprorelin acetate. Adv. Drug Deliv. Rev 1997; 28: 43–70
   PubMed Web of Science ®Google Scholar
• Kompella U.B., Lee V.H.L. Pharmacokinetics of peptide and protein drugs. Peptide and Protein Drug Delivery, V.H.L. Lee. Marcel Dekker Inc., New York 1991; 391–484
   Google Scholar
• Yamaguchi Y., Takenaga M., Kitagawa A., Ogawa Y., Mizushima Y., Igarashi R. Insulin-loaded biodegradable PLGA microcapsules: initial burst release controlled by hydrophilic additives. J. Control Rel. 2002; 81: 235–249
   PubMed Web of Science ®Google Scholar
• Takenaga M., Yamaguchi Y., Kitagawa A., Ogawa Y., Mizushima Y., Igarashi R. A novel sustained-release formulation of insulin with dramatic reduction in initial rapid release. J. Control. Rel. 2002; 79: 81–91
   PubMed Web of Science ®Google Scholar